Allelic variants of human beta-chemokine receptor 5 (CCR5) promoter: evolutionary relationships and predictable associations with HIV-1 disease progression (original) (raw)
- Full Paper
- Published: 29 September 1999
Genes & Immunity volume 1, pages 20–27 (1999)Cite this article
- 450 Accesses
- 37 Citations
- 3 Altmetric
- Metrics details
Abstract
Variability in the natural history of HIV-1 infection has been repeatedly associated with genetic variants in the beta-chemokine receptor 5 (CCR5) locus. While CCR5 coding sequences have demonstrated relatively limited variation, sequences of its promoter appear polymorphic in all major populations. Our studies revealed five major CCR5 promoter alleles with distributions that differed widely among the four distinct ethnic groups from Kigali, Rwanda and Bronx, New York. In particular, promoter allele P*0103 (G59029-T59353-T59356-A59402-C59653) was largely restricted to black subjects. The promoter allele P*0202 (A59029-C59353-C59356-A59402-T59653) was tightly linked to the slightly less frequent CCR2b-64I, a variant of the CCR2b gene, which is about 12.7 kbp upstream from the promoter region. Another closely related promoter allele P*0201 (A59029-C59353-C59356-A59402-C59653) exclusively carried the far less common CCR5-Δ32, a 32-bp deletion in the CCR5 coding sequence 2 kbp downstream from the promoter. The homozygous P*0201/*0201 genotype can be predicted as a risk factor for more rapid disease progression. Among human, chimpanzee, pig-tailed macaque, and sooty mangabey promoter allelic sequences, the apparent ancestral lineage of the promoter sequence (G59029-T59353-C59356-A59402-C59653 = human P*0102) was highly conserved across the primate species analyzed here while P*0201 and P*0202 arose more recently than the other three major alleles. Further effort to establish the mechanism by which CCR chemokine receptor polymorphisms govern the initiation and pathogenesis of primate lentivirus infection apparently requires fully detailed genotypic characterization of the affected populations.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 digital issues and online access to articles
$119.00 per year
only $19.83 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
Author information
Authors and Affiliations
- Division of Geographic Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, 35294, AL , USA
J Tang & RA Kaslow - Program in Epidemiology of Infection and Immunity, School of Public Health, University of Alabama at Birmingham, Birmingham, 35294, AL, USA
J Tang, C Rivers, C Costello & RA Kaslow - Department of Epidemiology, University of Alabama at Birmingham, Birmingham, 35294, AL , USA
S Allen & RA Kaslow - Department of Microbiology, University of Alabama at Birmingham, Birmingham, 35294, AL, USA
PN Fultz - National AIDS Control Program, BP 780, Kigali, Rwanda
E Karita - Department of Epidemiology and Social Medicine, Albert Einstein College of Medicine at Bronx Medical Center, Bronx, 10467, NY , USA
EE Schoenbaum
Authors
- J Tang
You can also search for this author inPubMed Google Scholar - C Rivers
You can also search for this author inPubMed Google Scholar - E Karita
You can also search for this author inPubMed Google Scholar - C Costello
You can also search for this author inPubMed Google Scholar - S Allen
You can also search for this author inPubMed Google Scholar - PN Fultz
You can also search for this author inPubMed Google Scholar - EE Schoenbaum
You can also search for this author inPubMed Google Scholar - RA Kaslow
You can also search for this author inPubMed Google Scholar
Additional information
This work has been supported jointly by grants AI41951 and AI40591 from NIAID, and grant DA04347 from NIDA
Rights and permissions
About this article
Cite this article
Tang, J., Rivers, C., Karita, E. et al. Allelic variants of human beta-chemokine receptor 5 (CCR5) promoter: evolutionary relationships and predictable associations with HIV-1 disease progression.Genes Immun 1, 20–27 (1999). https://doi.org/10.1038/sj.gene.6363640
- Received: 22 February 1999
- Revised: 29 March 1999
- Accepted: 02 April 1999
- Published: 29 September 1999
- Issue Date: 01 September 1999
- DOI: https://doi.org/10.1038/sj.gene.6363640